Metabolic Tumour Volume from PSMA PET/CT Scans of Prostate Cancer Patients during Chemotherapy—Do Different Software Solutions Deliver Comparable Results?

(1) Background: Prostate-specific membrane antigen (PSMA)-derived tumour volume (PSMA-TV) and total lesion PSMA (TL-PSMA) from PSMA PET/CT scans are promising biomarkers for assessing treatment response in prostate cancer (PCa). Currently, it is unclear whether different software tools for assessing...

Descripción completa

Detalles Bibliográficos
Autores principales: Hartrampf, Philipp E., Heinrich, Marieke, Seitz, Anna Katharina, Brumberg, Joachim, Sokolakis, Ioannis, Kalogirou, Charis, Schirbel, Andreas, Kübler, Hubert, Buck, Andreas K., Lapa, Constantin, Krebs, Markus
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7290891/
https://www.ncbi.nlm.nih.gov/pubmed/32397223
http://dx.doi.org/10.3390/jcm9051390

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7290891/
https://www.ncbi.nlm.nih.gov/pubmed/32397223
http://dx.doi.org/10.3390/jcm9051390

Ejemplares similares